Pharma channel feed

Ster­ling Phar­ma com­pletes ac­qui­si­tion of No­var­tis man­u­fac­tur­ing plant in Ire­land

3 years ago
Manufacturing

Ei­sai fol­lows fam­i­ly ties with name for new­ly ap­proved Alzheimer's drug Leqem­bi

3 years ago
Marketing

Q&A: Genen­tech's first mar­ket­ing chief Er­i­ca Tay­lor on lessons from the pan­dem­ic, and what's next for the Roche group

3 years ago
Marketing

What we're see­ing at JPM so far: Up­com­ing BD moves, pipeline up­dates and more

3 years ago

Big Phar­mas main­tain pause of Twit­ter ads, spend­ing drops to ze­ro for first week of 2023

3 years ago
Marketing

Up­dat­ed: Mod­er­na rounds out 2022 with $18.4B in vac­cine sales, boosts R&D bud­get for 2023

3 years ago
Coronavirus

Teva's opi­oid set­tle­ment moves for­ward with par­tic­i­pa­tion from 48 states

3 years ago
Law

As­traZeneca bets up to $1.8B on Cin­Cor and its ex-Roche drug for hy­per­ten­sion

3 years ago
Deals

At #JPM23, an­oth­er rare dis­ease buy­out as Ipsen ac­quires Al­bireo for $952M

3 years ago
Deals

No­var­tis of­floads neu­rode­vel­op­men­tal dis­or­der as­set to small Swiss biotech

3 years ago
Startups
Deals

#JPM23 kicks off with an ac­qui­si­tion as Chiesi inks all-cash $1B+ deal for Am­ryt

3 years ago
Deals

Emer­gent award­ed $379M+ to sup­ply the DOD with a skin de­con­t­a­m­i­na­tion lo­tion

3 years ago
Deals
Manufacturing

Ei­sai prices Alzheimer's drug at $26,500, be­low part­ner Bio­gen's Aduhelm

3 years ago
FDA+

BioN­Tech inks part­ner­ship with UK to speed up re­cruit­ment of mR­NA can­cer tri­als

3 years ago

FDA grants pri­or­i­ty re­views for Pfiz­er's Pre­vnar 20 for kids and Roche lym­phoma can­di­date

3 years ago
FDA+

Break­ing: FDA clears sec­ond Alzheimer's drug in 'foun­da­tion­al spark' for field

3 years ago
R&D
FDA+

Brands in de­mand: Keytru­da, Dupix­ent and Ozem­pic lead 2023 new sales pre­dic­tions — Eval­u­ate re­port

3 years ago
Marketing

Fate and J&J end deal that once promised $3B in mile­stones; biotech cuts staff

3 years ago
Deals

In­tel­lia plots piv­otal tri­als for lead pro­grams as it lays out key ob­jec­tives

3 years ago
Cell/Gene Tx

Bausch + Lomb tack­les glau­co­ma aware­ness and re­search fund­ing with non­prof­it part­ner in new cam­paign

3 years ago
Marketing

Ready for take­off: J&J's con­sumer health unit Ken­vue files for of­fi­cial sep­a­ra­tion

3 years ago

Sarep­ta march­es for­ward with its po­ten­tial DMD gene ther­a­py and an ex­pand­ed Catal­ent man­u­fac­tur­ing deal

3 years ago
Manufacturing

Klick Group hires McK­in­sey life sci­ence com­mer­cial­iza­tion chief to amp of­fer­ings

3 years ago
Marketing

Sanofi ex­pects Zan­tac ar­bi­tra­tion case with Boehringer In­gel­heim to be re­solved ear­ly this year

3 years ago
Law
First page Previous page 151152153154155156157 Next page Last page
A service from the Financial Times